내부자 거래

EDGAR

Celularity Inc

이사, 임원 및 10% 이상 주주가 SEC 양식 3, 4, 5로 보고한 거래이며, 각 제출 문서의 XML에서 읽었습니다. 코드와 그 설명은 SEC의 원문입니다.

양식 4는 거래 후 영업일 2일 이내에 제출해야 하므로 가장 최근 거래는 아직 제출되지 않았을 수 있습니다.

기간: 2025년 11월 17일 이후 날짜의 거래.

공개시장 매수(코드 P)
거래 0건, —주
공개시장 매도(코드 S)
거래 0건, —주

합계는 나열된 제출 거래를 더한 것이며, 보고된 내용을 센 것일 뿐 방향을 나타내지 않습니다.

53건 중 1–50건 표시

SEC 양식 3, 4, 5에 제출된 내부자 거래(최신순)
날짜보고자코드취득 또는 처분주식 수주당 가격(제출된 대로)가치(산출)거래 후 보유 주식 수직접 또는 간접규칙 10b5-1 체크란주석출처
2026년 9월 23일 2026년 9월 25일 제출Barach Philip Alan Director · 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,000,000) — 행사가 1.50
취득(A)192,771——2,000,000간접(I) See Footnote아니요
F1, F2
  • F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Philip Alan Director · 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,140,000) — 행사가 1.50
취득(A)2,140,000——2,140,000간접(I) See Footnote아니요
F4, F2
  • F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Philip Alan Director · 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (1,177,000) — 행사가 1.50
취득(A)1,177,000——1,177,000간접(I) See Footnote아니요
F5, F4, F2
  • F5 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants.
  • F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Philip Alan Director · 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00
취득(A)1,457,765——1,457,765간접(I) See Footnote아니요
F6, F2
  • F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Philip Alan Director · 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00
취득(A)1,457,765——1,457,765간접(I) See Footnote아니요
F7, F6, F2
  • F7 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
  • F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111026 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Daniele Wolf 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,000,000) — 행사가 1.50
취득(A)192,771——2,000,000간접(I) See Footnote아니요
F1, F2
  • F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Daniele Wolf 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,140,000) — 행사가 1.50
취득(A)2,140,000——2,140,000간접(I) See Footnote아니요
F4, F2
  • F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Daniele Wolf 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (1,177,000) — 행사가 1.50
취득(A)1,177,000——1,177,000간접(I) See Footnote아니요
F5, F4, F2
  • F5 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants.
  • F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Daniele Wolf 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00
취득(A)1,457,765——1,457,765간접(I) See Footnote아니요
F6, F2
  • F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Barach Daniele Wolf 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00
취득(A)1,457,765——1,457,765간접(I) See Footnote아니요
F7, F6, F2
  • F7 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
  • F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
  • F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-111027 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Philip Daniele Barach Family Trust 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,000,000) — 행사가 1.50
취득(A)192,771——2,000,000직접(D) 아니요
F1
  • F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.
제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Philip Daniele Barach Family Trust 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (2,140,000) — 행사가 1.50
취득(A)2,140,000——2,140,000직접(D) 아니요
F3
  • F3 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Philip Daniele Barach Family Trust 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (1,177,000) — 행사가 1.50
취득(A)1,177,000——1,177,000직접(D) 아니요
F4, F3
  • F4 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants.
  • F3 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.
제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Philip Daniele Barach Family Trust 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00
취득(A)1,457,765——1,457,765직접(D) 아니요
F5
  • F5 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 9월 23일 2026년 9월 25일 제출Philip Daniele Barach Family Trust 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (1,457,765) — 행사가 2.00
취득(A)1,457,765——1,457,765직접(D) 아니요
F6, F5
  • F6 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
  • F5 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.
제출 문서 열기 0001104659-26-111028 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 6월 19일 2026년 6월 23일 제출Barach Daniele Wolf 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,204,819) — 행사가 1.66
처분(D)1,204,819——0간접(I) See Footnote아니요
F1, F3
  • F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
  • F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-076681 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 6월 19일 2026년 6월 23일 제출Barach Daniele Wolf 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (839,160) — 행사가 2.00
처분(D)839,160——0간접(I) See Footnote아니요
F2, F1, F3
  • F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date.
  • F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
  • F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-076681 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 6월 19일 2026년 6월 23일 제출Philip Daniele Barach Family Trust 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,204,819) — 행사가 1.66
처분(D)1,204,819——0직접(D) 아니요
F1
  • F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
제출 문서 열기 0001104659-26-076683 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 6월 19일 2026년 6월 23일 제출Philip Daniele Barach Family Trust 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (839,160) — 행사가 2.00
처분(D)839,160——0직접(D) 아니요
F2, F1
  • F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date.
  • F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
제출 문서 열기 0001104659-26-076683 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 6월 19일 2026년 6월 23일 제출Barach Philip Alan 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Convertible Notes — 기초자산 Class A Common Stock (1,204,819) — 행사가 1.66
처분(D)1,204,819——0간접(I) See Footnote아니요
F1, F3
  • F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
  • F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-076682 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 6월 19일 2026년 6월 23일 제출Barach Philip Alan 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Warrants — 기초자산 Class A Common Stock (839,160) — 행사가 2.00
처분(D)839,160——0간접(I) See Footnote아니요
F2, F1, F3
  • F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date.
  • F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
  • F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.
제출 문서 열기 0001104659-26-076682 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Hariri Robert J Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
취득(A)3,2810—2,854,735직접(D) 아니요
F1
  • F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
제출 문서 열기 0001493152-26-016832 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Hariri Robert J Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
처분(D)1,1821.28
1,512.96

산출: 주식 수 × 주당 가격. 정확한 값 1512.96.

2,853,553직접(D) 아니요
F2
  • F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
제출 문서 열기 0001493152-26-016832 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Hariri Robert J Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

파생증권: Restricted Stock Units — 기초자산 Class A Common Stock (3,281)
처분(D)3,2810—0직접(D) 아니요
F3, F4
  • F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
  • F4 On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.
제출 문서 열기 0001493152-26-016832 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Haines John R Officer: Senior Exec Vice President
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
취득(A)1,6410—30,762직접(D) 아니요
F1
  • F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
제출 문서 열기 0001493152-26-016833 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Haines John R Officer: Senior Exec Vice President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
처분(D)5831.28
746.24

산출: 주식 수 × 주당 가격. 정확한 값 746.24.

30,179직접(D) 아니요
F2
  • F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
제출 문서 열기 0001493152-26-016833 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Haines John R Officer: Senior Exec Vice President
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

파생증권: Restricted Stock Units — 기초자산 Class A Common Stock (1,641)
처분(D)1,6410—0직접(D) 아니요
F3, F4
  • F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
  • F4 On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. The Class a common stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.
제출 문서 열기 0001493152-26-016833 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Brigido Stephen Officer: Pres., Functional Regeneration
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
취득(A)8210—9,742직접(D) 아니요
F1
  • F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
제출 문서 열기 0001493152-26-016834 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Brigido Stephen Officer: Pres., Functional Regeneration
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
처분(D)2681.28
343.04

산출: 주식 수 × 주당 가격. 정확한 값 343.04.

9,474직접(D) 아니요
F2
  • F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
제출 문서 열기 0001493152-26-016834 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 13일 2026년 4월 15일 제출Brigido Stephen Officer: Pres., Functional Regeneration
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

파생증권: Restricted Stock Units — 기초자산 Class A Common Stock (821)
처분(D)8210—0직접(D) 아니요
F3, F4
  • F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
  • F4 On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.
제출 문서 열기 0001493152-26-016834 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 15일 제출Ling Geoffrey M.D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)19,2310.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

256,026직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
  • F2 Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
제출 문서 열기 0001493152-26-002424 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 15일 제출Parks Diane L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)30,0000.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

520,021직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
  • F2 Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
제출 문서 열기 0001493152-26-002427 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 15일 제출LeVien Vincent Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)28,8470.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

153,847직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
  • F2 Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
제출 문서 열기 0001493152-26-002423 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 15일 제출Diamandis Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)20,3850.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

394,150직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
  • F2 Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
제출 문서 열기 0001493152-26-002425 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 14일 제출Parks Diane L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)30,0000—520,021직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-26-002297 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 14일 제출LeVien Vincent Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)28,8470—153,847직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-26-002300 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 14일 제출Diamandis Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)20,3850—394,150직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-26-002298 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 1월 12일 2026년 1월 14일 제출Ling Geoffrey M.D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)19,2310.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

256,026직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-26-002303 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출Parks Diane L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)125,0000.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

490,021직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029615 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출Parks Diane L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20
취득(A)156,2500—518,774직접(D) 아니요
F3
  • F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029615 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출Diamandis Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)125,0000.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

373,765직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029614 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출Diamandis Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20
취득(A)156,2500—518,774직접(D) 아니요
F3
  • F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029614 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출LeVien Vincent Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)125,0000.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

125,000직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029618 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출LeVien Vincent Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20
취득(A)156,2500—156,250직접(D) 아니요
F3
  • F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029618 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출Ling Geoffrey M.D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)125,0000.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

236,795직접(D) 아니요
F1, F2
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
  • F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029617 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 29일 2025년 12월 30일 제출Ling Geoffrey M.D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

파생증권: Stock Options — 기초자산 Class A Common Stock (156,250) — 행사가 1.20
취득(A)156,2500—1,490,996직접(D) 아니요
F3
  • F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
제출 문서 열기 0001493152-25-029617 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 19일 2025년 12월 22일 제출Ling Geoffrey M.D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)67,4160.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

111,795직접(D) 아니요
F1
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025.
제출 문서 열기 0001493152-25-028780 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 19일 2025년 12월 22일 제출Parks Diane L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)67,4160.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

365,021직접(D) 아니요
F1
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested and became exercisable on December 19, 2025.
제출 문서 열기 0001493152-25-028787 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 12월 19일 2025년 12월 22일 제출Diamandis Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)67,4160.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

248,765직접(D) 아니요
F1
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025.
제출 문서 열기 0001493152-25-028778 제출 문서의 XML에서 읽음 이 행에 이의 제기
2025년 11월 19일 2025년 11월 21일 제출Diamandis Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
취득(A)47,0420.00
0

산출: 주식 수 × 주당 가격. 정확한 값 0.00.

248,765직접(D) 아니요
F1
  • F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant.
제출 문서 열기 0001493152-25-024630 제출 문서의 XML에서 읽음 이 행에 이의 제기

기관 보유자(양식 13F)

2026-09-30에 끝나는 분기: 제출 문서 8,793건을 읽었으며 가장 최근 제출일은 2026년 11월 16일입니다. 2026-06-30에 끝난 이전 분기: 제출 문서 9,164건을 읽었습니다.

36건 중 1–36건 표시

기관 보유자, 보유량이 큰 순, 제출된 대로
운용사주식 수 또는 원금제출된 가치이전 분기 대비 차이출처
C V STARR CO INC 764,069 SH1,031,494 달러변동 없음 이전 분기: 764,069제출 문서 열기 0001140361-26-043078 2026년 11월 10일 제출 이 행에 이의 제기
VANGUARD CAPITAL MANAGEMENT LLC 646,444 SH872,699 달러25,339 많음 이전 분기: 621,105제출 문서 열기 0002100119-26-001711 2026년 11월 13일 제출 이 행에 이의 제기
GEODE CAPITAL MANAGEMENT, LLC 일부는 다른 운용사 명의로 보고됨167,150 SH225,697 달러변동 없음 이전 분기: 167,150제출 문서 열기 0001214717-26-000012 2026년 11월 6일 제출 이 행에 이의 제기
VANGUARD FIDUCIARY TRUST CO 121,516 SH164,047 달러41,642 많음 이전 분기: 79,874제출 문서 열기 0000933478-26-000017 2026년 11월 13일 제출 이 행에 이의 제기
UBS Group AG 일부는 다른 운용사 명의로 보고됨80,075 SH108,101 달러73,117 많음 이전 분기: 6,958제출 문서 열기 0001610520-26-000121 2026년 11월 10일 제출 이 행에 이의 제기
BlackRock, Inc. 일부는 다른 운용사 명의로 보고됨76,359 SH103,085 달러변동 없음 이전 분기: 76,359제출 문서 열기 0002012383-26-003985 2026년 11월 13일 제출 이 행에 이의 제기
STATE STREET CORP 일부는 다른 운용사 명의로 보고됨57,830 SH78,071 달러변동 없음 이전 분기: 57,830제출 문서 열기 0000093751-26-000747 2026년 11월 12일 제출 이 행에 이의 제기
NORTHERN TRUST CORP 일부는 다른 운용사 명의로 보고됨49,874 SH67,330 달러5,711 많음 이전 분기: 44,163제출 문서 열기 0000073124-26-000067 2026년 11월 16일 제출 이 행에 이의 제기
Biltmore Family Office, LLC 35,000 SH47,250 달러변동 없음 이전 분기: 35,000제출 문서 열기 0001398344-26-019404 2026년 11월 3일 제출 이 행에 이의 제기
HB Wealth Management, LLC 31,915 SH43,085 달러변동 없음 이전 분기: 31,915제출 문서 열기 0001172661-26-004668 2026년 10월 23일 제출 이 행에 이의 제기
Sky Investment Group LLC 29,920 SH40,392 달러이전 분기에 읽은 제출 문서에 없음 제출 문서 열기 0001941040-26-000786 2026년 10월 30일 제출 이 행에 이의 제기
ROYAL BANK OF CANADA 일부는 다른 운용사 명의로 보고됨18,000 SH24,000 달러18,000 적음 이전 분기: 36,000제출 문서 열기 0001140361-26-044123 2026년 11월 16일 제출 이 행에 이의 제기
JANE STREET GROUP, LLC 일부는 다른 운용사 명의로 보고됨17,403 SH23,494 달러11,310 적음 이전 분기: 28,713제출 문서 열기 0001595888-26-000162 2026년 11월 12일 제출 이 행에 이의 제기
IPG Investment Advisors LLC 17,169 SH23,178 달러변동 없음 이전 분기: 17,169제출 문서 열기 0001602237-26-000008 2026년 10월 30일 제출 이 행에 이의 제기
MERCER GLOBAL ADVISORS INC /ADV 일부는 다른 운용사 명의로 보고됨15,200 SH20,520 달러15,100 많음 이전 분기: 100제출 문서 열기 0000853758-26-000020 2026년 11월 16일 제출 이 행에 이의 제기
CITADEL ADVISORS LLC 옵션: Call 일부는 다른 운용사 명의로 보고됨14,300 SH19,305 달러이전 분기에 읽은 제출 문서에 없음 제출 문서 열기 0001104659-26-128228 2026년 11월 16일 제출 이 행에 이의 제기
GROUP ONE TRADING LLC 옵션: Call 9,700 SH13,095 달러이전 분기에 읽은 제출 문서에 없음 제출 문서 열기 0000932540-26-000017 2026년 11월 10일 제출 이 행에 이의 제기
BFC Planning, Inc. 7,713 SH10,413 달러변동 없음 이전 분기: 7,713제출 문서 열기 0001420506-26-002645 2026년 11월 13일 제출 이 행에 이의 제기
SIMPLEX TRADING, LLC 옵션: Call 6,000 SH8,100 달러이전 분기에 읽은 제출 문서에 없음 제출 문서 열기 0001488542-26-000013 2026년 11월 4일 제출 이 행에 이의 제기
Tower Research Capital LLC (TRC) 일부는 다른 운용사 명의로 보고됨3,323 SH4,486 달러1,788 적음 이전 분기: 5,111제출 문서 열기 0001533421-26-000010 2026년 11월 16일 제출 이 행에 이의 제기
WELLS FARGO COMPANY/MN 일부는 다른 운용사 명의로 보고됨2,500 SH3,375 달러변동 없음 이전 분기: 2,500제출 문서 열기 0000072971-26-000342 2026년 11월 16일 제출 이 행에 이의 제기
Vanguard Global Advisers, LLC 2,315 SH3,125 달러변동 없음 이전 분기: 2,315제출 문서 열기 0001811242-26-000017 2026년 11월 13일 제출 이 행에 이의 제기
SBI Securities Co., Ltd. 1,882 SH2,541 달러402 적음 이전 분기: 2,284제출 문서 열기 0001851815-26-000004 2026년 10월 22일 제출 이 행에 이의 제기
CALDWELL SUTTER CAPITAL, INC. 1,000 SH1,350 달러변동 없음 이전 분기: 1,000제출 문서 열기 0000702007-26-000013 2026년 11월 9일 제출 이 행에 이의 제기
CoreCap Advisors, LLC 500 SH675 달러변동 없음 이전 분기: 500제출 문서 열기 0001902501-26-000006 2026년 10월 8일 제출 이 행에 이의 제기
Global Retirement Partners, LLC 300 SH405 달러변동 없음 이전 분기: 300제출 문서 열기 0001580642-26-007620 2026년 11월 10일 제출 이 행에 이의 제기
Financial Perspectives, Inc 171 SH231 달러변동 없음 이전 분기: 171제출 문서 열기 0002003287-26-000005 2026년 11월 3일 제출 이 행에 이의 제기
SIMPLEX TRADING, LLC 옵션: Put 100 SH135 달러이전 분기에 읽은 제출 문서에 없음 제출 문서 열기 0001488542-26-000013 2026년 11월 4일 제출 이 행에 이의 제기
VALLEY NATIONAL ADVISERS INC 100 SH135 달러변동 없음 이전 분기: 100제출 문서 열기 0000773411-26-000007 2026년 10월 23일 제출 이 행에 이의 제기
BNP PARIBAS FINANCIAL MARKETS 일부는 다른 운용사 명의로 보고됨99 SH134 달러변동 없음 이전 분기: 99제출 문서 열기 0001166588-26-000012 2026년 11월 12일 제출 이 행에 이의 제기
JONES FINANCIAL COMPANIES LLLP 일부는 다른 운용사 명의로 보고됨82 SH113 달러변동 없음 이전 분기: 82제출 문서 열기 0001193125-26-459442 2026년 11월 13일 제출 이 행에 이의 제기
United Financial Planning Group LLC 19 SH26 달러변동 없음 이전 분기: 19제출 문서 열기 0002088337-26-000008 2026년 11월 4일 제출 이 행에 이의 제기
JPMORGAN CHASE CO 일부는 다른 운용사 명의로 보고됨16 SH22 달러변동 없음 이전 분기: 16제출 문서 열기 0000019617-26-000404 2026년 11월 12일 제출 이 행에 이의 제기
HARBOUR INVESTMENTS, INC. 15 SH20 달러변동 없음 이전 분기: 15제출 문서 열기 0000810121-26-000006 2026년 11월 9일 제출 이 행에 이의 제기
BARCLAYS PLC 일부는 다른 운용사 명의로 보고됨4 SH5 달러이전 분기에 읽은 제출 문서에 없음 제출 문서 열기 0000312069-26-000241 2026년 11월 6일 제출 이 행에 이의 제기
DANSKE BANK A/S 1 SH1 달러변동 없음 이전 분기: 1제출 문서 열기 0001104659-26-124081 2026년 11월 9일 제출 이 행에 이의 제기
이전 분기에는 있으나 최신 분기 제출 문서를 읽지 못한 운용사

아직 제출하지 않았을 수 있습니다. 최신 분기에 읽은 제출 문서에 없다는 것이 보유분을 매도했다는 뜻은 아닙니다.

  • Walleye Capital LLC 835,194 SH
  • Linden Advisors LP 550,119 SH
  • HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 350,000 SH
  • PEAK6 LLC 171,363 SH
  • Davidson Kempner Capital Management LP 150,800 SH
  • Context Capital Management, LLC 150,000 SH
  • CITADEL ADVISORS LLC 99,054 SH
  • Lombard Odier Asset Management (Europe) Ltd 84,919 SH
  • TWO SIGMA SECURITIES, LLC 65,609 SH
  • HRT FINANCIAL LP 56,591 SH
  • Corient Private Wealth LP 50,000 SH
  • KEYNOTE FINANCIAL SERVICES LLC 29,920 SH
  • CenterStar Asset Management, LLC 21,000 SH
  • Virtu Financial LLC 18,697 SH
  • CenterStar Asset Management, LLC 15,000 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,619 SH
  • IFP Advisors, Inc 12,000 SH
  • Clear Street Group Inc. 11,613 SH
  • Weaver Capital Management LLC 11,609 SH
  • Procyon Advisors, LLC 11,500 SH
  • GROUP ONE TRADING LLC 3,595 SH
  • SIMPLEX TRADING, LLC 2,188 SH
  • HighMark Wealth Management LLC 441 SH
  • WOLVERINE ASSET MANAGEMENT LLC 68 SH
  • MORGAN STANLEY 21 SH
  • TORNO CAPITAL, LLC 1 SH
  • 양식 13F는 13(f)조 대상 증권의 매수 포지션만 다룹니다. 공매도와 해당 목록 밖의 증권은 포함되지 않습니다.
  • 최신 분기를 아직 제출하지 않은 운용사는 0이 아니라 없는 것입니다. 제출 기한은 분기 종료 후 최대 45일입니다.
  • 차이는 두 분기말 시점 사이의 차이이며 거래가 아닙니다.
  • 다른 운용사 명의로 보고된 보유분은 그 운용사의 제출 문서에도 나타날 수 있으므로 행을 합산하지 않습니다.
  • 증권 목록이 이 회사로 연결하지 못하거나 모호하게 연결한 보유분은 표시하지 않습니다.

5% 보유자(스케줄 13D, 13G)

SEC 구조화 형식(2024년 말 이후)으로 제출된 스케줄을 여기서 읽습니다. 이전 스케줄은 자유 텍스트여서 읽지 않습니다.

5% 보유자, 최신 사건순, 제출된 대로
보유자해당 종류 대비 비율보유 주식 수사건일양식출처
PHILIP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share29.011,940,187.0009/23/2026 2026년 9월 28일 제출SCHEDULE 13D/A정정 3제출 문서 열기 0001104659-26-111279 이 행에 이의 제기
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share29.011,940,187.0009/23/2026 2026년 9월 28일 제출SCHEDULE 13D/A정정 3제출 문서 열기 0001104659-26-111279 이 행에 이의 제기
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share29.011,940,187.0009/23/2026 2026년 9월 28일 제출SCHEDULE 13D/A정정 3제출 문서 열기 0001104659-26-111279 이 행에 이의 제기
PHILIP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share15.85,514,686.0006/19/2026 2026년 6월 23일 제출SCHEDULE 13D/A정정 2제출 문서 열기 0001104659-26-076580 이 행에 이의 제기
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share15.85,514,686.0006/19/2026 2026년 6월 23일 제출SCHEDULE 13D/A정정 2제출 문서 열기 0001104659-26-076580 이 행에 이의 제기
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share15.85,514,686.0006/19/2026 2026년 6월 23일 제출SCHEDULE 13D/A정정 2제출 문서 열기 0001104659-26-076580 이 행에 이의 제기
PHILIP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share20.17,558,665.0004/20/2026 2026년 4월 22일 제출SCHEDULE 13D/A정정 1제출 문서 열기 0001104659-26-046494 이 행에 이의 제기
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share20.17,558,665.0004/20/2026 2026년 4월 22일 제출SCHEDULE 13D/A정정 1제출 문서 열기 0001104659-26-046494 이 행에 이의 제기
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share20.17,558,665.0004/20/2026 2026년 4월 22일 제출SCHEDULE 13D/A정정 1제출 문서 열기 0001104659-26-046494 이 행에 이의 제기
PHILP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share9.563,012,048.0012/19/2025 2026년 4월 3일 제출SCHEDULE 13D제출 문서 열기 0001104659-26-039490 이 행에 이의 제기
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share9.563,012,048.0012/19/2025 2026년 4월 3일 제출SCHEDULE 13D제출 문서 열기 0001104659-26-039490 이 행에 이의 제기
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share9.563,012,048.0012/19/2025 2026년 4월 3일 제출SCHEDULE 13D제출 문서 열기 0001104659-26-039490 이 행에 이의 제기
Dragasac Limited Class A Common Stock, par value $0.0001 per share23.86,335,63007/24/2025 2025년 7월 28일 제출SCHEDULE 13D/A정정 6제출 문서 열기 0000905148-25-002573 이 행에 이의 제기
Resorts World Inc Pte. Ltd. Class A Common Stock, par value $0.0001 per share13.34,100,00007/24/2025 2025년 7월 28일 제출SCHEDULE 13D/A정정 6제출 문서 열기 0000905148-25-002573 이 행에 이의 제기
Genting Berhad Class A Common Stock, par value $0.0001 per share33.910,435,63007/24/2025 2025년 7월 28일 제출SCHEDULE 13D/A정정 6제출 문서 열기 0000905148-25-002573 이 행에 이의 제기
Lim Kok Thay Class A Common Stock, par value $0.0001 per share4114,138,16107/24/2025 2025년 7월 28일 제출SCHEDULE 13D/A정정 6제출 문서 열기 0000905148-25-002573 이 행에 이의 제기
Lincoln Alternative Strategies LLC Class A Common Stock, $0.0001 par value per share00.0007/14/2025 2026년 2월 11일 제출SCHEDULE 13G/A정정 1제출 문서 열기 0001493152-26-006196 이 행에 이의 제기
Lincoln Alternative Strategies LLC Class A Common Stock, $0.0001 par value per share5.141,230,769.0007/14/2025 2025년 8월 27일 제출SCHEDULE 13G제출 문서 열기 0001641172-25-025647 이 행에 이의 제기

비율은 제출 문서가 지정한 종류에 대한 것이며 보유자가 밝힌 그대로입니다. 그룹 구성원은 각자 그룹의 주식을 보고하므로 행을 합산하지 않습니다.

읽은 내용

2004년 6월 14일부터 2026년 11월 16일까지의 제출 문서 2,216,605건을 읽음: 양식 3, 3/A, 4, 4/A, 5, 5/A.

아카이브를 아직 읽는 중이라 일부 연도는 불완전할 수 있습니다. 여기서 제출 수가 적은 해가 실제로 적게 제출되었다는 뜻은 아닙니다.

제출 연도별 읽은 문서
제출 연도읽은 문서
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
2022134,347
2023199,811
2024209,823
2025235,520
2026260,165

SEC가 XML을 요구하기 전의 제출 문서는 목록에만 있고 내용은 추출하지 않습니다.

Celularity Inc(으)로 돌아가기